1. Home
  2. ANGI vs RNA Comparison

ANGI vs RNA Comparison

Compare ANGI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Angi Inc.

ANGI

Angi Inc.

SELL

Current Price

$6.17

Market Cap

198.7M

ML Signal

SELL

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$8.00

Market Cap

222.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGI
RNA
Founded
1995
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.7M
222.5M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
ANGI
RNA
Price
$6.17
$8.00
Analyst Decision
Hold
Strong Buy
Analyst Count
8
4
Target Price
$8.00
★ $25.00
AVG Volume (30 Days)
★ 765.3K
428.8K
Earning Date
11-03-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1242.86
N/A
EPS
N/A
★ N/A
Revenue
★ $736,386,000.00
N/A
Revenue This Year
N/A
$84.55
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 47.60
N/A
52 Week Low
$4.26
$7.96
52 Week High
$15.88
$73.06

Technical Indicators

Market Signals
Indicator
ANGI
RNA
Relative Strength Index (RSI) 68.84 25.22
Support Level $4.59 N/A
Resistance Level $6.52 $14.05
Average True Range (ATR) 0.34 0.48
MACD 0.10 -0.06
Stochastic Oscillator 86.01 14.73

Price Performance

Historical Comparison
ANGI
RNA

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: